Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1999 2
2001 2
2005 2
2006 3
2009 1
2010 1
2012 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
The following terms were ignored: [, [, ], ]
The following terms were not found in PubMed: phenylcarbamoylformyl
Page 1
Dabigatran.
[No authors listed] [No authors listed] 2023 Jul 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Jul 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999803 Free Books & Documents. Review.
Diverse modes of 5'-[4-(aminoiminomethyl)phenyl]-[2,2'-bifuran]-5-carboximidamide (DB832) interaction with multi-stranded DNA structures.
Kaluzhny DN, Borisova OF, Shchyolkina AK. Kaluzhny DN, et al. Biopolymers. 2010 Jan;93(1):8-20. doi: 10.1002/bip.21287. Biopolymers. 2010. PMID: 19642208
The modes of binding of 5'-[4-(aminoiminomethyl)phenyl]-[2,2'-Bifuran]-5-carboximidamide (DB832) to multi-stranded DNAs: human telomere quadruplex, monomolecular R-triplex, pyr/pur/pyr triplex consisting of 12 T*(T x A) triplets, and DNA double helical hairpi …
The modes of binding of 5'-[4-(aminoiminomethyl)phenyl]-[2,2'-Bifuran]-5-carboximidamide (DB832) to multi-stranded DNAs …
Myelin like electrogenic filamentation and Liquid Microbial Fuel Cells Dataset.
D'Ugo E, Bertuccini L, Spadaro F, Giuseppetti R, Iosi F, Santavenere F, Giuliani F, Bruno M, Lovecchio N, Gioacchini S, Bucci P, Stellacci E, Bernardo A, Mukherjee A, Magurano F. D'Ugo E, et al. Data Brief. 2022 Jul 11;43:108447. doi: 10.1016/j.dib.2022.108447. eCollection 2022 Aug. Data Brief. 2022. PMID: 35864873 Free PMC article.
Synthesis and SAR of alkanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity.
Huang TL, Vanden Eynde JJ, Mayence A, Collins MS, Cushion MT, Rattendi D, Londono I, Mazumder L, Bacchi CJ, Yarlett N. Huang TL, et al. Bioorg Med Chem Lett. 2009 Oct 15;19(20):5884-6. doi: 10.1016/j.bmcl.2009.08.073. Epub 2009 Aug 23. Bioorg Med Chem Lett. 2009. PMID: 19736009 Free PMC article.
However, bisbenzamidines linked with shorter alkanediamide chains were the most potent compounds against P. carinii. N,N'-Bis[4-(aminoiminomethyl)phenyl] hexanediamide, 4 displayed potent inhibition (IC50=2-3 nM) against T. brucei and P. carinii, and w …
However, bisbenzamidines linked with shorter alkanediamide chains were the most potent compounds against P. carinii. N,N'-Bis[4-(a …
Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents.
Bovy PR, Tjoeng FS, Rico JG, Rogers TE, Lindmark RJ, Zablocki JA, Garland RB, McMackins DE, Dayringer H, Tóth MV, et al. Bovy PR, et al. Bioorg Med Chem. 1994 Sep;2(9):881-95. doi: 10.1016/s0968-0896(00)82038-6. Bioorg Med Chem. 1994. PMID: 7712124
The ethyl ester prodrug form was tested by oral administration to dogs and monitoring of the anti-platelet effect on ex vivo collagen induced platelet aggregation. From the structural studies reported, the 4-[[(aminoiminomethyl)phenyl]amino]-4-oxobutan …
The ethyl ester prodrug form was tested by oral administration to dogs and monitoring of the anti-platelet effect on ex vivo collagen induce …
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1.
Quan ML, Liauw AY, Ellis CD, Pruitt JR, Carini DJ, Bostrom LL, Huang PP, Harrison K, Knabb RM, Thoolen MJ, Wong PC, Wexler RR. Quan ML, et al. J Med Chem. 1999 Jul 29;42(15):2752-9. doi: 10.1021/jm980405i. J Med Chem. 1999. PMID: 10425086
We report a series of novel biaryl-substituted isoxazoline derivatives in which the biaryl moiety was designed to interact with the S(4) aryl-binding domain of the FXa active site. Several of the compounds herein have low nanomolar affinity for FXa, have good in vitro sele …
We report a series of novel biaryl-substituted isoxazoline derivatives in which the biaryl moiety was designed to interact with the S(4 …
Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.
Bondinell WE, Keenan RM, Miller WH, Ali FE, Allen AC, de Brosse CW, Eggleston DS, Erhard KF, Haltiwanger RC, Huffman WF, et al. Bondinell WE, et al. Bioorg Med Chem. 1994 Sep;2(9):897-908. doi: 10.1016/s0968-0896(00)82039-8. Bioorg Med Chem. 1994. PMID: 7712125
The direct design of the potent nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist, 8-[[[4- (aminoiminomethyl)phenyl]amino]carbonyl]-2,3,4,5-tetrahydro-3-oxo- 4- (2-phenylethyl)-1H-1,4-benzodiazepine-2-acetic acid, (3) (SB 20 …
The direct design of the potent nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist, 8-[[[4- (aminoiminomethyl) …
15 results